APC and breast cancer: While genetic alterations of Wnt pathway components, such as APC, β-catenin, axin and TCF7L2 are implicated in colorectal cancers, melanoma, gastric and hepatocellular carcinomas, they are rarely associated with breast cancer [12], [14], [20]–[25].